Skip to main content
Clinical Trials/ISRCTN06886935
ISRCTN06886935
Completed
未知

Development and evaluation of an intervention based around the national guidelines on the management of suspected encephalitis, and its evaluation through a cost-effectiveness analysis

niversity of Liverpool (UK)0 sites1,680 target enrollmentJuly 22, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Liverpool (UK)
Enrollment
1680
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Registry
who.int
Start Date
July 22, 2013
End Date
July 15, 2016
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Liverpool (UK)

Eligibility Criteria

Inclusion Criteria

  • Site inclusion criteria:
  • All centres will have a consultant and all centres must be equipped with the ability to perform, or have access to CT/MRI scans and have aseptic conditions for conducting a LP to be performed. Hospitals will be randomised as a unit to either the standard care or intervention arm. Study centres will be initiated once all global (e.g. local research and development \[R\&D] approval) and study\-specific conditions (e.g. training requirements) have been met, and all necessary documents have been returned to the Brain Infections UK coordinating centre.
  • Within this study, any patients who have suspected encephalitis within the recruited sites will be included in the study. The inclusion criteria for suspected encephalitis are:
  • Patients with suspected encephalitis
  • (a) Mandatory
  • Acute or sub\-acute (\<4 weeks) alteration in consciousness, cognition, personality or behaviour persisting for more than 24 hours. Personality/behaviour change includes: agitation, psychosis, somnolence, insomnia, catatonia, mood liability, altered sleep pattern and (in children): new onset enuresis, or irritability.
  • Plus ANY two of:
  • 1\. Fever (\> 38ºC) / prodromal illness ? acute or sub\-acute
  • 2\. Seizures: new onset
  • 3\. Focal neurological signs ? acute or sub\-acute onset. These include:

Exclusion Criteria

  • Site exclusion criteria:
  • Current participation in the ENCEPH UK programme
  • Added 07/01/2015:
  • Patient exclusion criteria
  • Any patient aged under 28 days upon the date of admission shall be excluded

Outcomes

Primary Outcomes

Not specified

Similar Trials